Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus

Clinical trial NCT01559025 · UNKNOWN

Trial details

NCT number: NCT01559025
Sponsor: Federal University of São Paulo
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Insulin Dependent Diabetes Juvenile Onset Diabetes Mellitus Autoimmune Diabetes

Start date: 2014-03-01
Primary completion: 2015-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.